Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
Weatherald J, Thakrar MV, Varughese RA, Kularatne M, Liu J, Harper L, Kiamanesh O, Fine N, Orlikow E, Nwaroh C, Thornton C, Swiston J, Kolkman L, Brunner NW, Helmersen D, Hirani N.
Weatherald J, et al. Among authors: brunner nw.
J Heart Lung Transplant. 2022 May;41(5):563-567. doi: 10.1016/j.healun.2022.01.002. Epub 2022 Jan 10.
J Heart Lung Transplant. 2022.
PMID: 35090807
Clinical Trial.